Market Overview

Cerus Announces Deal with Swiss Red Cross for Initial Deployment of INTERCEPT Blood System

Related CERS
Mid-Afternoon Market Update: NeoPhotonics Drops After Disappointing Q3 Results; Bristow Shares Spike Higher
Mid-Morning Market Update: Markets Open Lower; Humana Beats Q3 Estimates
First Midwest Bank Trust Division Buys iShares Russell Mid-Cap, iShares Core S&P 5……, ... (GuruFocus)

Cerus Corporation (NASDAQ: CERS) announced today that it has signed a two-year purchase agreement with two regional Swiss Red Cross Blood Services for deployment of the INTERCEPT Blood System for plasma in Lausanne and Zurich. These two pilot centers supply an estimated 15,000 plasma units annually.

Posted-In: News


Related Articles (CERS)

View Comments and Join the Discussion!